KEVIN VUONG: Open Payments
NPI 1124627435 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,474 in 47 payments from 19 companies in 2025. Trend: 2023 $556 · 2024 $943 · 2025 $1,474
Food & beverage: $1,474
| Company | Payments | Amount |
|---|---|---|
| Teleflex LLC | 9 | $341 |
| ABBVIE INC. | 9 | $245 |
| UROGEN PHARMA, INC. | 4 | $226 |
| Janssen Biotech, Inc. | 5 | $160 |
| PROGENICS PHARMACEUTICALS, INC. | 3 | $68 |
| Edap Technomed Inc | 1 | $62 |
| Dendreon Pharmaceuticals LLC | 2 | $60 |
| Sumitomo Pharma America, Inc. | 2 | $53 |
| Astellas Pharma US Inc | 2 | $50 |
| Merck Sharp & Dohme LLC | 1 | $29 |
Products named: BOTOX, UROLIFT, ERLEADA, BARRIGEL, ZUSDURI, XTANDI, PYLARIFY, FOCAL ONE.
Industry payments across CA — which companies pay providers there.
